Navigation Links
National Drug Development Accelerator Launched
Date:11/20/2008

LENEXA, Kan., Nov. 20 /PRNewswire/ -- KansasBio announced today a bioscience cluster activation initiative to promote the region's human health-care-related bioscience companies that serve the entire drug development continuum. Called the National Drug Development Accelerator (the Accelerator), the alliance comprises companies across Kansas and the Kansas City metropolitan area that represent many of the nation's preferred resources for drug development.

KansasBio says the Accelerator offers a full spectrum of drug development services. From discovery to post market, the alliance of companies offers comprehensive assets to bring pharmaceuticals and biotech drugs to market cost effectively and at a high level of quality.

"Kansas' collection of companies is the answer to the emerging outsourcing trend among pharmaceutical companies," said Angela Kreps, president of KansasBio. "During the last 5 years as pharmaceutical companies have increased outsourcing, and when development budgets are enduring additional scrutiny related to return on investment, our companies are busy bringing the biggest new drugs to market. We will continue to define the value proposition in a tenuous economy."

In the drug development process, where saving one day can mean saving millions of dollars, Kansas service providers have advanced clinical timelines to save pharmaceutical partners days and sometimes weeks. KansasBio cites local companies' responsiveness as one reason that there are 1,950 ongoing clinical trials in the Kansas region -- the fifth highest per capita in the United States. In areas of the state, the number of clinical trials providing access to new treatments has more than doubled during the last 4 years, according to KansasBio.

"The Kansas region has a 30-year history of expertise with the capabilities to go from the chemistry bench to the patient's bedside," said Michael Beckloff, president of Beckloff Associates. "Our cluster represents companies that have helped develop more than 50 of the world's top drugs. We can efficiently move drugs through the development pipeline and help pharmaceutical companies maximize market years and return on investment."

Kansas has a decades-long history of drug development and is home to preferred partners for major pharmaceutical companies. The state has one of the region's greatest geographic concentrations of experienced pharmaceutical development, clinical research and bioscience companies. To learn more about the Accelerator, visit http://www.NDDAccelerator.com.


'/>"/>
SOURCE KansasBio
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
6. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
7. Arrow International Files and Mails Definitive Proxy Materials
8. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Viragen International to Reverse Split Its Common Stock
11. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... , November 30, 2016 The global ... few players hold a dominant share in the overall ... Laboratories International, Inc., and Merck KGaA, held a lion,s ... Transparency Market Research observes that these companies are expected ... development products that are do not require rabbit pyrogen ...
(Date:11/30/2016)... VANCOUVER , Nov. 30, 2016 /PRNewswire/ -  Equicare ... coordination solutions, has been recognized as one of the ... 100, an annual international listing that distinguishes the top ... "We,ve pushed a great step forward this year continually ... growing our own customer base and team," says ...
(Date:11/30/2016)... -- Part of 5m$ Investment in Integrated Drug ... , ... today announced that it had successfully completed the expansion of ... increased the Screening Collection to over 400,000. The new compounds ... the company. This expansion, complemented by new robotics and compound ...
(Date:11/30/2016)... Triangle Park, NC (PRWEB) , ... November 30, ... ... development company engaged in the development of a new orally administered treatment for ... testing and neuroimaging results of a Phase 2a clinical trial of T3D-959 in ...
Breaking Biology Technology:
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):